{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:32:14Z","timestamp":1790685134098,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ijcard.2016.08.204","type":"journal-article","created":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T07:47:12Z","timestamp":1470988032000},"page":"390-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Procalcitonin: A new biomarker for the cardiologist"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6400-4949","authenticated-orcid":false,"given":"Philipp","family":"Schuetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori B.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.08.204_bb0005","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.jacc.2010.02.025","article-title":"Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial","volume":"55","author":"Maisel","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0010","first-page":"24","article-title":"Chest pain: differentiating cardiac from noncardiac causes","volume":"40","author":"Karnath","year":"2004","journal-title":"Hosp. Physician"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0015","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/cid\/cis1014","article-title":"Promising new assays and technologies for the diagnosis and management of infectious diseases","volume":"56","author":"Mitsuma","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0020","first-page":"w14079","article-title":"Biomarker-guided personalised emergency medicine for all - hope for another hype?","volume":"145","author":"Schuetz","year":"2015","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0025","first-page":"318","article-title":"Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections\u2013hope for hype?","volume":"139","author":"Schuetz","year":"2009","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2334-7-10","article-title":"Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia","volume":"7","author":"Muller","year":"2007","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0035","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/MCC.0b013e328363bd38","article-title":"Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis","volume":"19","author":"Schuetz","year":"2013","journal-title":"Curr. Opin. Crit. Care"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/QCO.0b013e32835d0bec","article-title":"Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia","volume":"26","author":"Schuetz","year":"2013","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0045","first-page":"396","article-title":"Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis","volume":"86","author":"Muller","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0050","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/315214","article-title":"Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options","volume":"181","author":"Gogos","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0055","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/01.CCM.0000134404.63292.71","article-title":"Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes","volume":"32","author":"Linscheid","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0060","first-page":"451","article-title":"Procalcitonin in bacterial infections\u2013hype, hope, more or less?","volume":"135","author":"Christ-Crain","year":"2005","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0065","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1183\/09031936.00166106","article-title":"Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators","volume":"30","author":"Christ-Crain","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0070","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1210\/en.2004-1424","article-title":"Autocrine\/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue","volume":"146","author":"Linscheid","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0075","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s15010-007-7065-0","article-title":"Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci","volume":"35","author":"Schuetz","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0080","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1378\/chest.09-2920","article-title":"Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial","volume":"138","author":"Muller","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0085","doi-asserted-by":"crossref","first-page":"R206","DOI":"10.1186\/cc9328","article-title":"Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study","volume":"14","author":"van Nieuwkoop","year":"2010","journal-title":"Crit. Care"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/viru.1.2.10488","article-title":"Guidance of antibiotic therapy with procalcitonin in lower respiratory tract infections: insights into the ProHOSP study","volume":"1","author":"Schuetz","year":"2010","journal-title":"Virulence"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0095","article-title":"Prognostic value of procalcitonin in community-acquired pneumonia","author":"Schuetz","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0100","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1164\/rccm.200512-1922OC","article-title":"Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial","volume":"174","author":"Christ-Crain","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1183\/09031936.00054507","article-title":"Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes","volume":"31","author":"Kruger","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0110","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.annemergmed.2008.01.003","article-title":"Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia","volume":"52","author":"Huang","year":"2008","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10096-008-0592-5","article-title":"Prognostic value of procalcitonin in Legionella pneumonia","volume":"28","author":"Haeuptle","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0120","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1097\/01.CCM.0000239116.01855.61","article-title":"Procalcitonin increase in early identification of critically ill patients at high risk of mortality","volume":"34","author":"Jensen","year":"2006","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.annemergmed.2006.10.020","article-title":"Procalcitonin test in the diagnosis of bacteremia: a meta-analysis","volume":"50","author":"Jones","year":"2007","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0130","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1378\/chest.11-2430","article-title":"Role of procalcitonin in managing adult patients with respiratory tract infections","volume":"141","author":"Schuetz","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0135","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/archinternmed.2011.318","article-title":"Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms","volume":"171","author":"Schuetz","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0140","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","article-title":"Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial","volume":"16","author":"de Jong","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0145","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jama.2013.697","article-title":"Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections","volume":"309","author":"Schuetz","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007498.pub2","article-title":"Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections","volume":"9","author":"Schuetz","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0155","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1515\/cclm-2014-1015","article-title":"Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective","volume":"53","author":"Schuetz","year":"2015","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0160","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/eurjhf\/hfr177","article-title":"Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial","volume":"14","author":"Maisel","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0165","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijcard.2014.06.022","article-title":"Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial","volume":"175","author":"Schuetz","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0170","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.161.19.2337","article-title":"Acute precipitants of congestive heart failure exacerbations","volume":"161","author":"Tsuyuki","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0175","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0196-0644(05)82777-5","article-title":"Effects of prehospital medications on mortality and length of stay in congestive heart failure","volume":"21","author":"Wuerz","year":"1992","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0180","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archinte.168.8.847","article-title":"Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF","volume":"168","author":"Fonarow","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0185","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/cc13181","article-title":"Procalcitonin testing for diagnosis and short-term prognosis in bacterial infection complicated by congestive heart failure: a multicenter analysis of 4698 cases","volume":"18","author":"Wang","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0190","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/clinchem\/48.5.788","article-title":"Sensitive immunoluminometric assay for the detection of procalcitonin","volume":"48","author":"Morgenthaler","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0195","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2009.1297","article-title":"Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial","volume":"302","author":"Schuetz","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0200","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.amjmed.2015.06.037","article-title":"Diagnostic and prognostic utility of procalcitonin in patients presenting to the emergency department with dyspnea","volume":"129","author":"Alba","year":"2016","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0205","first-page":"830614","article-title":"Infection after acute ischemic stroke: risk factors, biomarkers, and outcome","volume":"2011","author":"Wartenberg","year":"2011","journal-title":"Stroke Res. Treat."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0210","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1001\/archneurol.2009.176","article-title":"Preventive antibiotics for infections in acute stroke: a systematic review and meta-analysis","volume":"66","author":"van de Beek","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0215","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1747-4949.2012.00858.x","article-title":"STRoke Adverse outcome is associated WIth NoSocomial Infections (STRAWINSKI): procalcitonin ultrasensitive-guided antibacterial therapy in severe ischaemic stroke patients - rationale and protocol for a randomized controlled trial","volume":"8","author":"Ulm","year":"2013","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0220","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12028-009-9325-6","article-title":"Usefulness of serum procalcitonin levels for the early diagnosis of stroke-associated respiratory tract infections","volume":"14","author":"Hug","year":"2011","journal-title":"Neurocrit. Care."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0225","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s12035-015-9112-7","article-title":"Procalcitonin is a stronger predictor of long-term functional outcome and mortality than high-sensitivity C-reactive protein in patients with ischemic stroke","volume":"23","author":"Wang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0230","first-page":"981","article-title":"Infectious endocarditis: diagnosis and treatment","volume":"85","author":"Pierce","year":"2012","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0235","doi-asserted-by":"crossref","first-page":"795801","DOI":"10.1155\/2015\/795801","article-title":"Procalcitonin improves the Glasgow Prognostic Score for outcome prediction in emergency patients with cancer: a cohort study","volume":"2015","author":"Rast","year":"2015","journal-title":"Dis. Markers"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0240","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/1346-8138.12922","article-title":"Use of procalcitonin, C-reactive protein and white blood cell count to distinguish between lower limb erysipelas and deep vein thrombosis in the emergency department: a prospective observational study","volume":"42","author":"Rast","year":"2015","journal-title":"J. Dermatol."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0245","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002264","article-title":"Can we reduce negative blood cultures with clinical scores and blood markers? Results from an observational cohort study","volume":"94","author":"Laukemann","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0250","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1161\/01.CIR.0000126281.52345.52","article-title":"Procalcitonin and the early diagnosis of infective endocarditis","volume":"109","author":"Mueller","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0255","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ajem.2013.03.008","article-title":"Role of procalcitonin in the diagnosis of infective endocarditis: a meta-analysis","volume":"31","author":"Yu","year":"2013","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0260","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.amjmed.2010.07.018","article-title":"Procalcitonin in 759 patients clinically suspected of infective endocarditis","volume":"123","author":"Knudsen","year":"2010","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0265","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/S0735-1097(02)02953-4","article-title":"C-reactive protein and other inflammatory risk markers in acute coronary syndromes","volume":"41","author":"Blake","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0270","first-page":"205","article-title":"Procalcitonin in patients with acute myocardial infarction","volume":"114","author":"Remskar","year":"2002","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0275","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1253\/circj.CJ-10-0638","article-title":"Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease","volume":"75","author":"Sinning","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0280","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.resuscitation.2013.01.029","article-title":"Serum procalcitonin as a marker of post-cardiac arrest syndrome and long-term neurological recovery, but not of early-onset infections, in comatose post-anoxic patients treated with therapeutic hypothermia","volume":"84","author":"Engel","year":"2013","journal-title":"Resuscitation"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0285","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.resuscitation.2014.08.007","article-title":"The inflammatory response after out-of-hospital cardiac arrest is not modified by targeted temperature management at 33 degrees C or 36 degrees C","volume":"85","author":"Bro-Jeppesen","year":"2014","journal-title":"Resuscitation"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0290","first-page":"631062","article-title":"Assessment of procalcitonin to predict outcome in hypothermia-treated patients after cardiac arrest","volume":"2011","author":"Stammet","year":"2011","journal-title":"Crit. Care Res. Pract."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0295","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.resuscitation.2013.03.015","article-title":"Procalcitonin for prognostication after cardiac arrest: another piece of the puzzle?","volume":"84","author":"Varon","year":"2013","journal-title":"Resuscitation"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0300","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1741-7015-9-107","article-title":"Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future","volume":"9","author":"Schuetz","year":"2011","journal-title":"BMC Med."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0305","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/cid\/cis464","article-title":"Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis","volume":"55","author":"Schuetz","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0310","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0300-9572(03)00164-3","article-title":"Procalcitonin serum levels after out-of-hospital cardiac arrest","volume":"59","author":"Fries","year":"2003","journal-title":"Resuscitation"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0315","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/shk.0b013e3180488154","article-title":"Increased plasma levels of soluble triggering receptor expressed on myeloid cells 1 and procalcitonin after cardiac surgery and cardiac arrest without infection","volume":"28","author":"Adib-Conquy","year":"2007","journal-title":"Shock"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0320","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2431-8-18","article-title":"Acute-phase reactants after paediatric cardiac arrest. Procalcitonin as marker of immediate outcome","volume":"8","author":"Los Arcos","year":"2008","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0325","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jcrc.2008.10.012","article-title":"Influence of mild therapeutic hypothermia on the inflammatory response after successful resuscitation from cardiac arrest","volume":"24","author":"Fries","year":"2009","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0330","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12028-009-9318-5","article-title":"Comparison of the predictability of neurological outcome by serum procalcitonin and glial fibrillary acidic protein in postcardiac-arrest patients","volume":"12","author":"Hayashida","year":"2010","journal-title":"Neurocrit. Care."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0335","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2362.2010.02259.x","article-title":"Serum procalcitonin, C-reactive protein and white blood cell levels following hypothermia after cardiac arrest: a retrospective cohort study","volume":"40","author":"Schuetz","year":"2010","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0340","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.resuscitation.2013.01.004","article-title":"Procalcitonin after cardiac arrest - an indicator of severity of illness, ischemia\u2013reperfusion injury and outcome","volume":"84","author":"Annborn","year":"2013","journal-title":"Resuscitation"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0345","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.resuscitation.2012.09.037","article-title":"Value of procalcitonin as an outcome-parameter after cardiac arrest","volume":"84","author":"Hottenrott","year":"2013","journal-title":"Resuscitation"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0350","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/viru.1.2.10488","article-title":"Guidance of antibiotic therapy with procalcitonin in lower respiratory tract infections: insights into the ProHOSP study","volume":"1","author":"Schuetz","year":"2010","journal-title":"Virulence"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0355","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2217\/bmm.15.29","article-title":"Should procalcitonin be measured routinely in acute decompensated heart failure?","volume":"9","author":"Loncar","year":"2015","journal-title":"Biomark. Med"},{"key":"10.1016\/j.ijcard.2016.08.204_bb0360","article-title":"Procalcitonin predicts long-term mortality in patients with acute heart failure","volume":"16","author":"Mollar","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0365","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejim.2014.12.009","article-title":"Procalcitonin and long-term prognosis after an admission for acute heart failure","volume":"26","author":"Villanueva","year":"2015","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.08.204_bb0370","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.ajem.2012.04.009","article-title":"Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients","volume":"30","author":"Cinar","year":"2012","journal-title":"Am. J. Emerg. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316319118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316319118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T03:50:53Z","timestamp":1601005853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316319118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":74,"alternative-id":["S0167527316319118"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.08.204","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Procalcitonin: A new biomarker for the cardiologist","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.08.204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}